On April 6, 2025, Edward M. Christie, III, President, Chief Executive Officer and director of Spirit Aviation Holdings, Inc. (the “Company”), stepped down from his role with the Company and the Board of Directors (the “Board”).
Timothy M. Oxley, Chief Financial Officer (“CFO”) of MasterCraft Boat Holdings, Inc. (the “Company”) announced his resignation as CFO, effective June 30, 2025
On April 2, 2025, Peter A. Scott informed Healthpeak Properties, Inc. (the “Company”) of his resignation from his position as Chief Financial Officer of the Company.
On April 7, 2025, NRG Energy, Inc. (the “Company”) issued a press release announcing that Rasesh Patel, Executive Vice President, NRG Consumer, has notified the Company of his retirement from the Company, effective May 19, 2025.
On April 3, 2025, Kenneth Miller resigned his employment and position as Chief Commercial Officer of KORU Medical Systems, Inc. (the “Company”), effective immediately, to pursue a Chief Executive Officer role at an organization that does not compete with the Company.
Departed
Michael Gibbs
Senior Vice President, General Counsel and Corporate Secretary
T2 Biosystems, Inc.
Effective
2025-03-18
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On March 18, 2025, Michael Gibbs notified the Company of his termination of that certain Consulting Agreement between himself and the Company, dated February 15, 2025 and his resignation from his position as the Company’s Senior Vice President, General Counsel and Corporate Secretary.
Departed
Laura Adams
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
John Sperzel
Chief Executive Officer and President
T2 Biosystems, Inc.
Effective
2025-03-31
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel notified the Company of his termination of that certain Consulting Agreement between himself and the Company, dated February 15, 2025 and his resignation from his position as the Company’s Chief Executive Officer and President.
Departed
John W. Cumming
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
Robin Toft
Director
T2 Biosystems, Inc.
Effective
2025-03-31
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
Departed
Seymour Liebman
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
David Elsbree
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
John Sprague
Chief Financial Officer and Corporate Treasurer
T2 Biosystems, Inc.
Effective
2025-04-03
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John Sprague notified the Company of his resignation from his position as the Company’s Chief Financial Officer and Corporate Treasurer.
Departed
John Sperzel
Director
T2 Biosystems, Inc.
Effective
2025-03-31
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
Effective April 4, 2025, Christopher R. Delaney, President, Europe, Middle East and Africa (“EMEA”), is on a leave of absence from his position with The Goodyear Tire & Rubber Company (the “Company”).
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
On April 4, 2025, Rodney Adkins informed PayPal Holdings, Inc. (“PayPal” or the “Company”) that he will not stand for re-election to PayPal’s Board of Directors (“Board”) when his current term expires at PayPal’s 2025 Annual Meeting of Stockholders (“2025 Annual Meeting”).
In addition, on April 2, 2025, Glenn P. Marino notified the Company of his decision to retire from the Board immediately following the 2025 Annual Meeting.
On April 2, 2025, Vikram A. Atal, President and Chief Executive Officer of PRA Group, Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) of his decision to retire as President and Chief Executive Officer and as a member of the Board, effective on June 17, 2025, immediately following the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
Departed
Scott D. Deverell
Corporate Controller and Principal Accounting Officer
On April 1, 2025, Scott D. Deverell notified Transcat, Inc. (the “Company”) of his intention to retire from his position as Corporate Controller and Principal Accounting Officer of the Company.
On April 2, 2025, David Lazar resigned as President and as member of the Board of Directors (the “Board”) of the Company, with such resignation becoming effective April 2, 2025
Effective as of April 4, 2025, Samuel Haskell, Marcelo Lemos and Ned Siegel resigned from the Board and, to the extent applicable, all committees thereof.
Effective as of April 4, 2025, Samuel Haskell, Marcelo Lemos and Ned Siegel resigned from the Board and, to the extent applicable, all committees thereof.
Effective as of April 4, 2025, Samuel Haskell, Marcelo Lemos and Ned Siegel resigned from the Board and, to the extent applicable, all committees thereof.
Departed
Andrew Kucharchuk
Chief Financial Officer and member of the Board of Directors
On April 3, 2025, Rajat Dhanda and Daniel J. Sullivan, each a member of the board of directors (the “Board”) of the Company, notified the Company of their decisions to step down from their positions on the Board, which resignations became effective on that day.
On April 3, 2025, Rajat Dhanda and Daniel J. Sullivan, each a member of the board of directors (the “Board”) of the Company, notified the Company of their decisions to step down from their positions on the Board, which resignations became effective on that day.
On the Closing Date, April 1, 2025, Mr. Takehiro Abe resigned from his positions as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, and Treasurer.
Departed
Takehiro Abe
Director
AIS Holdings Group, Inc.
Successor
Ryohei Uetaki
Filed
April 7, 2025, 7:59 PM ET
Additionally, Mr. Abe resigned from his role as Director, with his resignation becoming effective on the 10th day after the mailing of the Company’s information statement on Schedule 14F-1 to the Company’s stockholders.
Departed
Rajat Dhanda
Director
ARES INDUSTRIAL REAL ESTATE INCOME TRUST Inc.
Effective
2025-04-02
Successor
Martin A. Edmondson
Filed
April 7, 2025, 7:59 PM ET
On April 2, 2025, Rajat Dhanda, a member of the board of directors (the “Board”) of Ares Industrial Real Estate Income Trust Inc. (referred to herein as the “Company,” “we,” “our,” or “us”), notified the Company of his decision to step down from his position on the Board, which became effective on that day.
Departed
Scott Recknor
Head of Asset Management
ARES INDUSTRIAL REAL ESTATE INCOME TRUST Inc.
Filed
April 7, 2025, 7:59 PM ET
On April 1, 2025, Scott Recknor, the Company’s Head of Asset Management, notified the Company of his decision to retire.
On April 2, 2025, Robert C. Griffin, a director of the Company since July 2005, and current Chairman of the Board of the Company, informed the Company that he will be retiring from the Board of the Company, without standing for re-election at the 2025 Annual Meeting of Stockholders.
On April 4, 2025, Kenneth M. Greenwood, Chief Product Architect, notified Healthcare Integrated Technologies, Inc. (the “Company”) of his resignation from all positions with the Company, effective immediately.
On March 31, 2025, Michael R. Edwards notified Caleres, Inc. (the “Company”) of his decision to resign as the Company’s Division President – Famous Footwear, effective May 2, 2025.
Retirement of Gerald Ng: Gerald Ng, Vice President and Chief Financial Officer of Data I/O Corporation (the “Company”), announced his planned retirement and upcoming transition, which is expected to take place in the second quarter of 2025.
E. Robinson McGraw, the Company’s Executive Chairman and the Chairman of the Board and of the Bank Board, agreed with the Company that he would resign as an officer and employee of the Company and the Bank, effective May 1, 2025 (the “Transition Date”)
Dr. Keswani will succeed Dr. Roberts, who has served as Chief Medical Officer for the past seven years, and who agreed to remain with the Company in a strategic advisory role following her succession by Dr. Keswani.
Departed
Thomas Krywe
Interim Chief Financial Officer, principal financial officer and principal accounting officer
on March 18, 2025, the Board approved, effective on April 1, 2025, (i) the removal of Thomas Krywe as interim Chief Financial Officer, principal financial officer and principal accounting officer of the Company and (ii) the appointment of Alison Engel as Chief Financial Officer, principal financial officer and principal accounting officer of the Company.
Kathy Vrabeck retired from the Company as its Chief Operating Officer, effective as of April 1, 2025.
Departed
Paul L. Berns
Director
Unity Biotechnology, Inc.
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
On April 3, 2025, Paul L. Berns informed the Board of Directors (the “Board”) of UNITY Biotechnology, Inc. (“Unity” or the “Company”) of his resignation as a member of the Board of the Company, and all of the committees of the Board on which he serves, in each case, effective at the close of business on April 4, 2025.
Each of Ramesh Gopalakrishnan and Jeffrey S. McCreary notified the Board of Directors (the “Board”) of Benchmark Electronics, Inc. (the “Company”) on April 2, 2025 and April 3, 2025, respectively, of his intent not to stand for re-election at the Company’s 2025 annual meeting of shareholders to be held on May 14, 2025 (the “Meeting”) upon the expiration of his term.
Each of Ramesh Gopalakrishnan and Jeffrey S. McCreary notified the Board of Directors (the “Board”) of Benchmark Electronics, Inc. (the “Company”) on April 2, 2025 and April 3, 2025, respectively, of his intent not to stand for re-election at the Company’s 2025 annual meeting of shareholders to be held on May 14, 2025 (the “Meeting”) upon the expiration of his term.
On April 2, 2025, the Company and its President, L. Jay Cross, mutually agreed not to renew Mr. Cross’ employment agreement upon the expiration of its current term on December 1, 2025, which shall be treated as a non-renewal by the Company under his employment agreement.
Departed
James B. Miller, Jr.
Director
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.